| Jamie Ann Bastek Finger, MD | |
|
600 E Marshall St Ste 203, West Chester, PA 19380-4453 | |
| (610) 738-2740 | |
| Not Available |
| Full Name | Jamie Ann Bastek Finger |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 19 Years |
| Location | 600 E Marshall St Ste 203, West Chester, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952466062 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD432478 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Penn - Medical Group | 6204730955 | 3031 |
News Archive
Researchers from the Peninsula Medical School in Plymouth (UK), the Memorial Sloan-Kettering Cancer Center in New York, Cornell University in New York, Weil Medical College in New York and the Center for Neural Tumour Research in Los Angeles, have for the first time identified a key mechanism that makes certain cells become tumorous in the brain. The resulting tumours occur most often spontaneously but can also occur in numbers as part of the inherited disease Neurofibromatosis type 2.
A team of tumor immunologists in France and Switzerland has established an improved, reliable immune monitoring tool that allows for more accurate measurement of the number, subtype, and activity of cancer antigen-specific CD4+ T cells in cancer patients treated with therapeutic cancer vaccines. The new technology may significantly aid tumor immunologists around the world who are working to improve the effectiveness of this emerging and highly promising class of immune system-based cancer therapies.
Despite being at an increased risk for cancers associated with the human papillomavirus, the first comprehensive national survey found that HPV vaccination rates for childhood cancer survivors lag well behind the national average and that health care providers often fail to recommend the vaccine.
During embryonic development, the entire nervous system, the skin and the sensory organs emerge from a single sheet of cells known as the ectoderm. While there have been extensive studies of how this sheet forms all these derivatives, it hasn't been possible to study the process in humans - until now.
› Verified 3 days ago
| Entity Name | University Of Penn - Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235527342 PECOS PAC ID: 6204730955 Enrollment ID: O20141111000091 |
News Archive
Researchers from the Peninsula Medical School in Plymouth (UK), the Memorial Sloan-Kettering Cancer Center in New York, Cornell University in New York, Weil Medical College in New York and the Center for Neural Tumour Research in Los Angeles, have for the first time identified a key mechanism that makes certain cells become tumorous in the brain. The resulting tumours occur most often spontaneously but can also occur in numbers as part of the inherited disease Neurofibromatosis type 2.
A team of tumor immunologists in France and Switzerland has established an improved, reliable immune monitoring tool that allows for more accurate measurement of the number, subtype, and activity of cancer antigen-specific CD4+ T cells in cancer patients treated with therapeutic cancer vaccines. The new technology may significantly aid tumor immunologists around the world who are working to improve the effectiveness of this emerging and highly promising class of immune system-based cancer therapies.
Despite being at an increased risk for cancers associated with the human papillomavirus, the first comprehensive national survey found that HPV vaccination rates for childhood cancer survivors lag well behind the national average and that health care providers often fail to recommend the vaccine.
During embryonic development, the entire nervous system, the skin and the sensory organs emerge from a single sheet of cells known as the ectoderm. While there have been extensive studies of how this sheet forms all these derivatives, it hasn't been possible to study the process in humans - until now.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jamie Ann Bastek Finger, MD 600 E Marshall St Ste 203, West Chester, PA 19380-4453 Ph: (610) 738-2740 | Jamie Ann Bastek Finger, MD 600 E Marshall St Ste 203, West Chester, PA 19380-4453 Ph: (610) 738-2740 |
News Archive
Researchers from the Peninsula Medical School in Plymouth (UK), the Memorial Sloan-Kettering Cancer Center in New York, Cornell University in New York, Weil Medical College in New York and the Center for Neural Tumour Research in Los Angeles, have for the first time identified a key mechanism that makes certain cells become tumorous in the brain. The resulting tumours occur most often spontaneously but can also occur in numbers as part of the inherited disease Neurofibromatosis type 2.
A team of tumor immunologists in France and Switzerland has established an improved, reliable immune monitoring tool that allows for more accurate measurement of the number, subtype, and activity of cancer antigen-specific CD4+ T cells in cancer patients treated with therapeutic cancer vaccines. The new technology may significantly aid tumor immunologists around the world who are working to improve the effectiveness of this emerging and highly promising class of immune system-based cancer therapies.
Despite being at an increased risk for cancers associated with the human papillomavirus, the first comprehensive national survey found that HPV vaccination rates for childhood cancer survivors lag well behind the national average and that health care providers often fail to recommend the vaccine.
During embryonic development, the entire nervous system, the skin and the sensory organs emerge from a single sheet of cells known as the ectoderm. While there have been extensive studies of how this sheet forms all these derivatives, it hasn't been possible to study the process in humans - until now.
› Verified 3 days ago
Richard J Mansfield, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 915 Old Fern Hill Rd, Bldg. D, Suite 600, West Chester, PA 19380 Phone: 610-692-3434 Fax: 610-692-9005 | |
William R Atkins, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 915 Old Fern Hill Rd, Bldg D Suite 600, West Chester, PA 19380 Phone: 610-692-3434 Fax: 610-692-9005 | |
Jennifer Beauchamp Akins, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 915 Old Fern Hill Rd, Bldg. D, Suite 600, West Chester, PA 19380 Phone: 610-692-3434 Fax: 610-692-9005 | |
Robert L Giuntoli Ii, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 440 E Marshall St Ste 101, West Chester, PA 19380 Phone: 610-738-2500 Fax: 610-738-2540 | |
Melissa L Delaney, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 606 E Marshall St, Suite 205, West Chester, PA 19380 Phone: 610-429-9101 Fax: 610-429-9105 | |
Dianne D Hotmer, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 915 Old Fern Hill Rd., Bldg D, Suite 600, West Chester, PA 19380 Phone: 610-692-3434 Fax: 610-692-9005 | |
Dr. Sara Shaw Nicholas, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 780 E Market St Ste 105, West Chester, PA 19382 Phone: 610-649-9021 Fax: 484-266-7352 |